Collaborating investigators at the University of Hawaii and Southern California have established a substantial cohort comprised of minorities (African-Americans, Hispanics, Japanese) and Whites. The cohort of 202,136 individuals has been characterized by questionnaires regarding detailed dietary histories, past medical histories and other lifestyle characteristics, and is being followed for all incident cancer cases utilizing population-based cancer registries in each location. This cohort is of sufficient size and heterogeneity to study the relationship between environmental risk factors, as determined primarily by the questionnaire, and genes that may be important alone or as sources of potential interaction in determining the risk of sporadic cancers of the colorectum, prostate, and breast. The proposed design maximizes the efficiency of the cohort by utilizing a nested case-cohort control design. A total of 400 cohort-controls will be randomly selected from each ethnic/sex group and blood will be collected from these cohort controls and from all incident cases of colorectum, prostate, and breast cancer. Specifically, this proposal will investigate polymorphisms in candidate genes (NAT2, GSTM1, CYP1A1, SRD5A2, AR, EDH17B2, CYP17, and ER), that might alter metabolism of relevant endogenous or exogenous exposures and their interactions with dietary variables (e.g., saturated fat and fiber intake) and other exogenous exposures (e.g., hormone replacement therapy) that affect the risk of these three cancers. In addition to case control comparisons, the design allows for comparison of the frequency of these genetic polymorphisms across ethnic groups.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA063464-05
Application #
6172579
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Seminara, Daniela
Project Start
1996-09-30
Project End
2001-04-30
Budget Start
2000-08-01
Budget End
2001-04-30
Support Year
5
Fiscal Year
2000
Total Cost
$942,733
Indirect Cost
Name
University of Southern California
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
Ferreiro-Iglesias, Aida; Lesseur, Corina; McKay, James et al. (2018) Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nat Commun 9:3927
Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330
Wang, Wen; Xu, Zack Z; Costanzo, Michael et al. (2017) Pathway-based discovery of genetic interactions in breast cancer. PLoS Genet 13:e1006973
Hoffman, Joshua D; Graff, Rebecca E; Emami, Nima C et al. (2017) Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk. PLoS Genet 13:e1006690
Mercader, Josep M; Liao, Rachel G; Bell, Avery D et al. (2017) A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes. Diabetes 66:2903-2914
Milne, Roger L (see original citation for additional authors) (2017) Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet 49:1767-1778
Machiela, Mitchell J; Zhou, Weiyin; Karlins, Eric et al. (2016) Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun 7:11843
Wyszynski, Asaf; Hong, Chi-Chen; Lam, Kristin et al. (2016) An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Hum Mol Genet 25:3863-3876

Showing the most recent 10 out of 171 publications